A coordination guide for people with multiple sclerosis in the Netherlands and UAE considering stem cell therapy abroad. The crucial difference between MSC and HSCT, regulation at home, travel from Amsterdam and Dubai, costs, and honest expectations. StemCell Longevita coordinates access to care and does not replace your neurologist.
Multiple sclerosis care in the Netherlands is well organised through specialist MS centres with broad access to licensed disease-modifying therapies (DMTs) and rehabilitation. In the UAE, patients in Dubai and Abu Dhabi access high-quality neurology and modern DMTs. Despite this, some patients — particularly those with active disease or those focused on symptoms and quality of life — research cell-based options not offered as routine care at home. StemCell Longevita is an international patient coordination platform based in Istanbul; we are not a treatment provider and we do not replace your neurologist.
Two entirely different procedures are commonly called "stem cell therapy" for MS. HSCT (haematopoietic stem cell transplant) uses chemotherapy to reset the immune system, is delivered in specialist transplant centres, has the strongest evidence in highly active relapsing-remitting MS, and carries significant risk. MSC therapy is a gentler outpatient infusion aimed at immune modulation and quality of life, with an earlier-stage evidence base. StemCell Longevita coordinates MSC therapy, not HSCT, and we make sure patients understand which is which before any decision. MSC therapy is not a cure and never a reason to stop a DMT — that decision belongs to your own neurologist.
MSC therapy for MS is not approved or reimbursed in the Netherlands under EU/EMA rules and is not a standard approved pathway in the UAE. Istanbul is roughly 3.5 hours from Amsterdam and 4.5 hours from the Gulf, with English and Dutch consultation and Arabic-speaking coordination support, and logistics planned around fatigue and mobility. A typical stay is 5–7 days. Coordinated treatment is typically 60–80% less than comparable private clinics in Western Europe, quoted individually after medical review. Patients should continue their prescribed DMT and rehabilitation and keep their Dutch MS centre or Emirati neurologist informed before and after travel.
Related articles: Stem Cell Therapy for Multiple Sclerosis (MS): Current Research & Treatment Options | Stem Cell Therapy for Autoimmune Diseases (2026 Research) | Cerebral Palsy Stem Cell Therapy Abroad: A Guide for Families in the Netherlands & UAE
Related treatments: Multiple Sclerosis Stem Cell Therapy | Autoimmune Disease Stem Cell Therapy